港股 12 月投资策略:11 月的回调为 2026 年赢得确定空间

Group 1 - The report emphasizes that the adjustment in the Hong Kong stock market in November has created space for growth in 2026, with a focus on sectors such as AI, materials, and innovative pharmaceuticals [2][64][82] - The report highlights the importance of AI in driving productivity improvements across industries, particularly in the software sector, where per capita income has increased from 750,000 to 870,000 yuan over the past five years [1][59][61] - The report notes that the "anti-involution" trend is expected to positively impact PPI recovery and overall corporate profitability, with a significant reduction in losses for struggling companies [1][55][58] Group 2 - The report suggests that the AI sector remains a key focus for 2026, driven by the need for domestic hardware production and the expectation of more AI applications being implemented [2][82] - The materials and industrial sectors are expected to benefit from the anti-involution trend, with upstream metals and certain industrial enterprises poised to gain [2][82] - The report indicates that the innovative pharmaceutical sector is stable and worth holding, with potential for growth if new business development projects are released [2][82] Group 3 - The report discusses the performance of the Hong Kong stock market in November, noting a slight adjustment of 0.2% in the Hang Seng Index, with significant sector differentiation [64][66] - It highlights that the consumer and innovative pharmaceutical sectors showed positive performance, while technology and automotive sectors faced declines [64][66] - The report mentions that the inflow of southbound funds reached 117.2 billion yuan in November, indicating strong willingness from Chinese capital to invest in Hong Kong stocks despite market downturns [75][82]